Brief Report: Pre-treatment Angiogenic Cytokines Predict Response to Chemoimmunotherapy in Patients with CLL

類似資料

• Direct and Complement Dependent Cytotoxicity in CLL Cells from Patients with High Risk Early Stage Chronic Lymphocytic Leukemia (CLL) Treated with Alemtuzumab and Rituximab
  著者:: Zent, Clive S., 等
  出版事項: (2008)
• Ofatumumab-based chemoimmunotherapy is effective and well tolerated in patients with previously untreated CLL
  著者:: Shanafelt, Tait, 等
  出版事項: (2013)
• Pentostatin and Rituximab Therapy for Previously Untreated B-CLL
  著者:: Kay, Neil E., 等
  出版事項: (2010)
• MBL or CLL: Which Classification Best Categorizes the Clinical Course of Patients with an Absolute Lymphocyte Count ≥5 × 10(9)/L but a B-cell Lymphocyte Count <5 × 10(9)/L?
  著者:: Shanafelt, Tait D., 等
  出版事項: (2008)
• Phase II Trials of Single Agent Anti-VEGF Therapy for Patients with Chronic Lymphocytic Leukemia (CLL)
  著者:: Shanafelt, Tait, 等
  出版事項: (2010)